The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Sleep-Related Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes
Open accessAbstract
Given that iatrogenic hypoglycemia often occurs during the night in people with type 1 diabetes, we tested the hypothesis that physiological, and the resulting behavioral, defenses against developing hypoglycemia—already compromised by absent glucagon and attenuated epinephrine and neurogenic symptom responses—are further compromised during sleep in type 1 diabetes. To do so, we studied eight adult patients with uncomplicated type 1 diabetes and eight matched nondiabetic control subjects with hyperinsulinemic stepped hypoglycemic clamps (glucose steps of ∼85, 75, 65, 55, and 45 mg/dl) in the morning (0730–1230) while awake and at night (2100–0200) while awake throughout and while asleep from 0000 to 0200 in random sequence. Plasma epinephrine (P = 0.0010), perhaps norepinephrine (P = 0.0838), and pancreatic polypeptide (P = 0.0034) responses to hypoglycemia were reduced during sleep in diabetic subjects (the final awake versus asleep values were 240 ± 86 and 85 ± 47, 205 ± 24 and 148 ± 17, and 197 ± 45 and 118 ± 31 pg/ml, respectively), but not in the control subjects. The diabetic subjects exhibited markedly reduced awakening from sleep during hypoglycemia. Sleep efficiency (percent time asleep) was 77 ± 18% in the diabetic subjects, but only 26 ± 8% (P = 0.0109) in the control subjects late in the 45-mg/dl hypoglycemic steps. We conclude that autonomic responses to hypoglycemia are reduced during sleep in type 1 diabetes, and that, probably because of their reduced sympathoadrenal responses, patients with type 1 diabetes are substantially less likely to be awakened by hypoglycemia. Thus both physiological and behavioral defenses are further compromised during sleep. This sleep-related hypoglycemia-associated autonomic failure, in the context of imperfect insulin replacement, likely explains the high frequency of nocturnal hypoglycemia in type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hormone-fuel interrelationships during fasting.
Cahill, G. F., Herrera, M. G., Morgan, A. P., Soeldner, J. S., Steinke, J., Levy, P. L., Reichard, G. A., & Kipnis, D. M. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105481 · Cited by 1,036
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794 · cited 9×
“The reduced cortisol response to hypoglycemia during sleep in diabetic subjects is relevant to the suggestion that it is the cortisol response to prior hypoglycemia that mediates reduced autonomic (including epinephrine) and symptomatic responses to subsequent hypoglycemia (25– 26), that is, that cortisol is the media…”
InfluentialSelf-citationDagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471
Self-citationSchwartz, N. S., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112884 · Cited by 394 · cited 2×
“0 mU kg 1 min (1)) stepped hypoglycemic clamps (hourly steps at 85, 75, 65, 55, and 45 mg/dl) (11) were performed on three occasions in random, computer-generated sequence in both groups.”
Self-citationHypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Segel, S. A., Paramore, D. S., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.3.724 · Cited by 337
Self-citationTowler, D. A., Havlin, C. E., Craft, S., & Cryer, P. (1993) · Diabetes · doi:10.2337/diab.42.12.1791 · Cited by 258 · cited 2×
“, the symptom nervous/anxious can be blocked by administration of catecholamine antagonists) (12), it is reasonable to attribute the reduced awakening from sleep in the patients to their reduced sympathoadrenal responses during sleep.”
Self-citationDavis, S. N., Shavers, C., Costa, F., & Mosqueda-Garcia, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118839 · Cited by 173
Hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1115 · Cited by 152 · cited 4×
“The reduced cortisol response to hypoglycemia during sleep in diabetic subjects is relevant to the suggestion that it is the cortisol response to prior hypoglycemia that mediates reduced autonomic (including epinephrine) and symptomatic responses to subsequent hypoglycemia (25– 26), that is, that cortisol is the media…”
Influential
Research works printed but not linked: 17
- The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986,1993 · DOI · Paper page
- The United Kingdom Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837–853,1998 · DOI · Paper page
- The Diabetes Control and Complications Trial Research Group: Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46: 271–286,1997 · DOI · Paper page
- Bendtson I, Rosenfalck AM, Binder C: Nocturnal versus diurnal hormonal counterregulation to hypoglycemia in type 1 (insulin-dependent) diabetes patients. Acta Endocrinol 128: 109–115,1993 · DOI
- Jones TW, Porter P, Sherwin RS, Davis EA, O’Leary P, Frazer F, Byrne G, Stick S, Tamborlane WV: Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 338: 1657–1662,1998 · DOI · Paper page
- Rechtschaffen A, Kales A (Eds.): A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages in Human Subjects. Los Angeles,: UCLA Brain Information Service/Brain Research Institute,1968
- Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH: Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26: 22–29,1977 · DOI
- Ensinck J: Immunoassays for glucagon. In Handbook of Experimental Pharmacology. Vol 66. Lefebrve P, Ed. New York, Springer Verlag,1983, p. 203–221 · DOI
- Gingerich RL, Lacy PE, Chance RE, Johnson MG: Regional pancreatic concentration and in-vitro secretion of canine pancreatic polypeptide, insulin, and glucagon. Diabetes 27: 96–101,1978 · DOI
- Schalch D, Parker M: A sensitive double antibody radioimmunoassay for growth hormone in plasma. Nature 703: 1141–1142,1964 · DOI · Paper page
- Farmer RW, Pierce CE: Plasma cortisol determination: radioimmunoassay and competitive protein binding compared. Clin Chem 20: 411–414,1974 · DOI · Paper page
- Hosaka K, Kijuchi T, Mitsuhida N, Kawaguchi A: A new colorimetric method for the determination of free fatty acids with acyl-CoA synthetase and acyl-CoA oxidase. J Biochem (Tokyo) 89: 1799–1803,1981 · DOI
- Pinter J, Hayaski J, Watson J: Enzymatic assay of glycerol, dihydroxyacetone and glyceraldehyde. Arch Biochem Biophys 121: 404–414,1967 · DOI · Paper page
- Lowry O, Passoneau J, Hasselberger F, Schultz D: Effect of ischemia on known substrates and co-factors of the glycolytic pathway of the brain. J Biol Chem 239: 18–30,1964 · DOI · Paper page
- Perriello G, DeFeo P, Torlone E, Fanelli C, Santuesanio F, Brunetti P, Bolli GB: The dawn phenomenon in type 1 (insulin dependent) diabetes mellitus: magnitude, frequency, variability and dependence on glucose counterregulation and insulin sensitivity. Diabetes 34: 21–28,1991 · DOI
- Davis SN, Shavers C, Davis B, Costa F: Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. J Clin Invest 100: 429–438,1997 · DOI
- Fanelli CG, Paramore DS, Hershey T, Terkamp C, Ovalle F, Craft S, Cryer PE: Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes mellitus. Diabetes 47: 1920–1927,1998 · DOI
Cited by
Pathophysiology of migraine: a disorder of sensory processing
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00034.2015 · Cited by 1,998
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citationFrancis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Self-citation
Metadata
- Authors
- Banarer, S., & Cryer, P. E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2003-05-01
- Volume
- 52
- Issue
- 5
- Pages
- 1195-1203
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2147769512
- Cited by
- 187
- References
- 9
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sleep-Related Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes. https://app.cochat.ai/papers/10.2337/diabetes.52.5.1195
- The paper
- Banarer, S., & Cryer, P. E. (2003). Sleep-Related Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes. Diabetes. https://doi.org/10.2337/diabetes.52.5.1195
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.